Quantum Computing Inc. announced new leadership appointments as the Company readies for an active 2024 with an anticipated market-disruptive product release schedule.  William (Bill) J. McGann, Ph.D., a globally recognized leader in commercialization of innovative technology, has been appointed CEO of Quantum Computing Inc. Dr. McGann succeeds QCi's co-founder Robert Liscouski who remains Chairman of the Board to help oversee the Company's growth and expansion. Dr. McGann has a decade-long track record for transforming credible science into practical technology in steps of innovation, engineering, and leadership. In his role as QCi's CTO, Dr. McGann has driven the launch of QCi products in the areas of quantum optimization machines, reservoir computing for AI, quantum remote sensing, and quantum random number generation in 2023.  Bill and the team are leading the charge in the Company's mission to provide "accessible and affordable" quantum technology to the world.  Over the course of his professional career, Dr. McGann has held numerous business and technology leadership positions.

Dr. McGann began his entrepreneurial journey in 1990, where he was a co-founder of a disruptive technology innovation company, Ion Track Instruments. There, he and the team created a revolutionary new explosives trace detection technology and methodology that is widely deployed around the world today. After successfully capturing a majority of the global market share in this industry, he sold Ion Track to GE and formed the GE Security business unit in 2002, where he continued to create new technologies to further grow the industry.

 Since then, Dr. McGann has led and driven innovative product design in several businesses, both large and small, which include United Technologies, Implant Sciences Corporation, L3 Harris Corp., and then Leidos as CTO of the Security and Automation division. Dr. McGann received his Ph.D. in Chemical Physics from the University of Connecticut and holds undergraduate degrees in both chemistry and biology. He has authored over 70 research proposals (SBIR) for the U.S. government, dozens of scientific publications, and 26 patents in the areas of nuclear, chemical and biological detection technologies.

Mr. Liscouski intends to use his more than 35 years of national security experience, including his service as the first U.S. Assistant Secretary for Infrastructure Protection of the U.S. Department of Homeland Security, President of Implant Sciences Corporation, Global Director of Information Assurance at the Coca-Cola Company, and a visiting fellow at the Center for Strategic and International Studies in Washington, D.C. to further support the Company's progress in commercializing its highly innovative technology, while providing strategic direction and corporate governance to grow shareholder value.  In his role as Chairman, Mr. Liscouski will remain active in guiding the business strategy and direction.